Search Results - robert+yu

3 Results

Sort By:

Methods and Compositions for Treating Neurodegenarative Diseases

The current state of the art: Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and multiple sclerosis pose devastating threats to both patients and their caregivers. Although palliative measurements are available to manage the disease symptoms, effective...

Published: 11/28/2022 | Inventor(s): Robert Yu, Yutaka Itokazu

Keywords(s):

Category(s): Therapeutics

Development of Peptide Mimics of GM1 Ganglioside

Tech ID: 2012-004 Title: Peptide Mimics for Treatment of GM-1 Associated Diseases Including Cholera and Guillain-Barre SyndromeCurrent State of the Art: Ganglioside GM1-associated diseases or infections are prevalent worldwide, and hundreds of millions of people are infected, or diagnosed, with ganglioside GM1-associated diseases each year. Exemplary...

Published: 6/19/2020 | Inventor(s): Robert Yu, Han-Chung Wu, Seigo Usuki

Keywords(s):

Category(s): Therapeutics

Development of Novel Therapies for Experimental Guillain-Barre Syndrome Using Ganglioside-Like Phage-Peptide

Current State of the Art:Guillain Barre syndrome is currently treated by administering pain relievers and other palliative forms of care to reduce the symptoms associated with the disease. Guillain Barre currently affects about 1 out of 50,000 people world-wide and in some instances has proven to be fatal due to limited treatments readily available...

Published: 4/28/2020 | Inventor(s): Robert Yu, Seigo Usuki

Keywords(s): Guillain-Barre, Phage-Peptide, Therapeutics

Category(s): Therapeutics